Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Coronavirus disease	4/232	0.00012150057084905025	0.006777623444822183	22.923976608187136	-63.412309433922275	CSF2;CSF3;STAT1;TNF
KEGG_2021_Human	Hematopoietic cell lineage	3/99	0.00020131554786600544	0.006777623444822183	35.589285714285715	-70.42440314178907	CSF2;CSF3;TNF
KEGG_2021_Human	IL-17 signaling pathway	3/94	0.00017260861398757182	0.006777623444822183	37.56828885400314	-73.71479219141467	CSF2;CSF3;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	3/131	0.0004602084037564585	0.011620262194850576	26.584821428571427	-54.62268457986884	CSF2;HLA-A;TNF
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.013604731713482414	50.175	-57.95352918467438	HLA-A;TNF
KEGG_2021_Human	Allograft rejection	2/38	0.0009469209383415865	0.013604731713482414	55.77777777777778	-62.87407127134141	HLA-A;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	3/181	0.0011822602400977265	0.013604731713482414	18.996789727126806	-40.00053498134924	STAT1;TNF;TXN
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.013604731713482414	48.94512195121951	-56.84526782917664	HLA-A;TNF
KEGG_2021_Human	JAK-STAT signaling pathway	3/162	0.000856615716023289	0.013604731713482414	21.318059299191376	-44.62403509135876	CSF2;CSF3;STAT1
KEGG_2021_Human	Malaria	2/50	0.0016370061401984127	0.013778135013336641	41.770833333333336	-50.1560330081587	CSF3;TNF
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.013778135013336641	17.769924812030077	-37.496518500419114	CSF2;HLA-A;STAT1
KEGG_2021_Human	Epstein-Barr virus infection	3/202	0.0016236545858167558	0.013778135013336641	16.946877243359655	-35.79178563433967	HLA-A;STAT1;TNF
KEGG_2021_Human	Autoimmune thyroid disease	2/53	0.0018378173017361363	0.01427842672887306	39.299019607843135	-47.75438384041307	HLA-A;TSHR
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.014777932967166925	15.579365079365079	-32.91284230349772	CSF2;HLA-A;TNF
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.017870599687572458	31.765873015873016	-40.07734547796954	STAT1;TNF
KEGG_2021_Human	Prolactin signaling pathway	2/70	0.0031848593502604382	0.017870599687572458	29.41176470588235	-37.553176952571945	FOXO3;STAT1
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.017870599687572458	13.800705467372135	-29.076248648200146	CSF2;FOXO3;TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	2/68	0.0030081604419031007	0.017870599687572458	30.310606060606062	-38.524679686703344	CSF2;TNF
KEGG_2021_Human	Antigen processing and presentation	2/78	0.003939415117888246	0.01989404634533564	26.289473684210527	-34.099339569929285	HLA-A;TNF
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.01989404634533564	26.643333333333334	-34.49723066158141	STAT1;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.02298451447237127	11.412915851272016	-23.74866982495136	CSF2;CSF3;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.024912369365885503	20.331632653061224	-27.120602948412195	STAT1;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.024912369365885503	19.524509803921568	-26.130280011490946	STAT1;TNF
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.024912369365885503	19.92	-26.61700675496218	CSF2;TNF
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.024912369365885503	21.914835164835164	-29.03004575134454	CSF2;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.024912369365885503	19.524509803921568	-26.130280011490946	STAT1;TNF
KEGG_2021_Human	Human papillomavirus infection	3/331	0.006599251035795172	0.024912369365885503	10.113240418118467	-20.757683091358754	HLA-A;STAT1;TNF
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.024912369365885503	19.524509803921568	-26.130280011490946	CSF2;TNF
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.026842622727562437	18.086363636363636	-24.33571316400054	CSF2;TNF
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.026842622727562437	18.086363636363636	-24.33571316400054	STAT1;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.03310625019746094	15.886	-21.510038502238015	STAT1;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.03814123945190317	14.472627737226277	-19.639406588988233	TNF;TXN
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.04507049164161728	12.847402597402597	-17.429441058365175	FOXO3;HLA-A
KEGG_2021_Human	Necroptosis	2/159	0.015618487202540639	0.04507049164161728	12.597133757961783	-17.083187709957596	STAT1;TNF
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.04507049164161728	12.762903225806452	-17.312716751580805	STAT1;TNF
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.045402811595745954	12.35625	-16.748364182562245	STAT1;TNF
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.04948738697614722	11.614705882352942	-15.707848772731996	STAT1;TNF
KEGG_2021_Human	Tuberculosis	2/180	0.019755026308062106	0.05224768986660132	11.081460674157304	-14.950240051620256	STAT1;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.05224768986660132	6.556709956709956	-12.239051897711217	HLA-A;STAT1;TNF
KEGG_2021_Human	Chemokine signaling pathway	2/192	0.0223068963273402	0.056324913226534004	10.365789473684211	-13.920708621090329	FOXO3;STAT1
KEGG_2021_Human	Human immunodeficiency virus 1 infection	2/212	0.026851997557997137	0.06614760374043197	9.354761904761904	-12.440530405951861	HLA-A;TNF
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.07213160409604903	8.794843049327355	-11.607417281005194	HLA-A;TNF
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.08496313814080812	7.915991902834008	-10.280113155611538	TNF;TXN
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.08663165263433263	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.10076495942558197	24.790123456790123	-13.876145105511855	TNF
KEGG_2021_Human	ABC transporters	1/45	0.05436047130022726	0.11934689667201002	20.262626262626263	-11.690056551619103	ABCG2
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.11934689667201002	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.13775899840055778	15.896825396825397	-9.424000900813787	TNF
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.13775899840055778	5.480113636363637	-6.479364551821025	CSF3;FOXO3
KEGG_2021_Human	Endometrial cancer	1/58	0.06956147443988561	0.13775899840055778	15.61598440545809	-9.271975415581295	FOXO3
KEGG_2021_Human	Regulation of lipolysis in adipocytes	1/55	0.06607320562588742	0.13775899840055778	16.48971193415638	-9.74227359341278	TSHR
KEGG_2021_Human	Viral myocarditis	1/60	0.07188046794101291	0.13961398580850584	15.08286252354049	-8.981081638876871	HLA-A
KEGG_2021_Human	Mitophagy	1/68	0.0811045146521906	0.15041352184203444	13.26865671641791	-7.96724592924887	FOXO3
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.15041352184203444	12.880837359098228	-7.74542097629872	TNF
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.15041352184203444	13.47138047138047	-8.082458738692866	CSF2
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.15041352184203444	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Non-small cell lung cancer	1/72	0.0856855265026792	0.15182873994334387	12.514866979655713	-7.534346814915346	FOXO3
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.15191405616749007	11.841481481481482	-7.141387005986298	TNF
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.15191405616749007	11.841481481481482	-7.141387005986298	STAT1
KEGG_2021_Human	Thyroid hormone synthesis	1/75	0.0891077855134448	0.15191405616749007	12.003003003003004	-7.236197160831004	TSHR
KEGG_2021_Human	Bile secretion	1/90	0.10604677818396174	0.17001150153301803	9.961298377028713	-6.010407578745034	ABCG2
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.17001150153301803	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.17001150153301803	10.075757575757576	-6.080768259179883	STAT1
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.1708853048672908	9.739926739926739	-5.8737398650795125	STAT1
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.17172439182557703	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.17253035587012772	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.1747640591362948	8.764576457645765	-5.262086311101535	FOXO3
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.1747640591362948	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.1747640591362948	8.764576457645765	-5.262086311101535	TNF
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.17545166433882728	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.17674863547683725	8.2668743509865	-4.943743954376122	TNF
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.17674863547683725	8.345911949685535	-4.994589105830365	STAT1
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.18384460158955673	7.4858757062146895	-4.435243302362896	FOXO3
KEGG_2021_Human	AMPK signaling pathway	1/120	0.13907692219429554	0.18384460158955673	7.4220354808590105	-4.393179099544486	FOXO3
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.18384460158955673	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Thyroid hormone signaling pathway	1/121	0.14015875566728583	0.18384460158955673	7.359259259259259	-4.351741094826131	STAT1
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.18384460158955673	7.4858757062146895	-4.435243302362896	STAT1
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.19540909333528078	6.7846153846153845	-3.968927686510734	FOXO3
KEGG_2021_Human	Systemic lupus erythematosus	1/135	0.15517650047822218	0.19839020947215746	6.5787728026534	-3.830244937455702	TNF
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.19859441930183908	6.480392156862745	-3.763669230249352	TNF
KEGG_2021_Human	Measles	1/139	0.15942370386618251	0.19878758136400534	6.384863123993559	-3.698840756963446	STAT1
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.20027128000050365	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	Cell adhesion molecules	1/148	0.16890973234869874	0.20554075864118765	5.987150415721844	-3.427000500776257	HLA-A
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.20695724994197043	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.20695724994197043	5.82560706401766	-3.3156870475343334	HLA-A
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.20695724994197043	5.70995670995671	-3.235678410841787	TNF
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.24833646431691644	4.5823152995927865	-2.441961042053517	CSF2
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.2512217587950716	4.462585034013605	-2.3563138595912863	TNF
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.25450174731409647	4.326732673267327	-2.2588473265567357	HLA-A
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.25450174731409647	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.26076157142844647	4.058397932816537	-2.065502377074288	TSHR
KEGG_2021_Human	Lipid and atherosclerosis	1/215	0.23655445762047492	0.26076157142844647	4.077881619937695	-2.079575623138921	TNF
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.29198401937957397	3.4603806994245243	-1.6315316807371463	HLA-A
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.29198401937957397	3.503584229390681	-1.6629804039719844	TXN
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.3094489580946491	3.184640522875817	-1.4307154955453085	TNF
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.32606351680030765	2.9484262419416005	-1.2588658824557653	TNF
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.3649511004486571	2.5254901960784313	-0.9533164047874388	TSHR
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.380873293569843	2.3584328129782675	-0.8341701676241932	TNF
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.3811852569402181	2.32487922705314	-0.8103995559567543	TNF
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.4592157405893584	1.7801218940459447	-0.4367315309409891	TNF
KEGG_2021_Human	Pathways in cancer	1/531	0.4935522426966286	0.4935522426966286	1.580293501048218	-0.3089273055464	STAT1
